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In 1974, at the Medical Policlinic of the University of Zürich, German-born physician-
scientist Andreas Grüntzig (1939–1985) for the first time applied a balloon-tipped catheter to
re-open a severely stenosed femoral artery, a procedure, which he initially called “per-
cutaneous transluminal dilatation”. Balloon angioplasty as a therapy of atherosclerotic
vascular disease, for which Grüntzig and Charles T. Dotter (1920–1985) received a nom-
ination for the Nobel Prize in Physiology or Medicine in 1978, became one of the most
successful examples of translational medicine in the twentieth century. Known today as
percutaneous transluminal angioplasty (PTA) in peripheral arteries or percutaneous translu-
minal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI) in coronary
arteries, balloon angioplasty has become the method of choice to treat patients with acute
myocardial infarction or occluded leg arteries. On the occasion of the 40th anniversary
of balloon angioplasty, we summarize Grüntzig’s life and career in Germany, Switzerland,
and the United States and also review the developments in vascular medicine from the
1890s to the 1980s, including Dotter’s first accidental angioplasty in 1963.The work of pio-
neers of catheterization, including Pedro L. Fariñas in Cuba, André F. Cournand in France,
Werner Forssmann, Werner Porstmann and Eberhard Zeitler in Germany, António Egas
Moniz and Reynaldo dos Santos in Portugal, Sven-Ivar Seldinger in Sweden, and Barney
Brooks,Thomas J. Fogarty, Melvin P. Judkins, Richard K. Myler, Dickinson W. Richards, and
F. Mason Sones in the United States, is discussed. We also present quotes by Grüntzig and
excerpts from his unfinished autobiography, statements of Grüntzig’s former colleagues
and contemporary witnesses, and have included hitherto unpublished historic photographs
and links to archive recordings and historic materials. This year, on June 25, 2014, Andreas
Grüntzig would have celebrated his 75th birthday. This article is dedicated to his memory.
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ATHEROSCLEROTIC VASCULAR DISEASE: AN ‘INTENTION TO
TREAT’
Atherosclerosis of arterial blood vessels represents the major
cause of illness, disability, and death in most of the world’s
industrialized countries, with numbers increasing also in devel-
oping countries (1–4). Due to the multifactorial nature of
atherosclerotic vascular disease, no specific treatment is avail-
able (1, 2, 5), and its prevention and therapy continue to pose
great tasks for physicians, healthcare providers, and govern-
ments (6). Advances in understanding, diagnosis, and treatment
of vascular disease have been made possible through discov-
eries in pathology (7–9), biochemistry (10), molecular biology
(11), genetics (12), pharmacology (13, 14), surgery (15–21), as
well as in engineering technology, which resulted in new modal-
ities to restore blood flow in diseased blood vessels (22–25).
However, because of the multiple factors causally involved in
atherogenesis (1, 5), attempts to deal with this disease had to
be based on an ‘intention to treat’ rather than an ‘intention to
cure’ (5).
In the early 1970s, German-born physician-scientist Andreas
Grüntzig, M.D. (1939–1985) by inventing balloon angioplasty
at the Medical Policlinic of the University of Zürich made one
of the most important technological and therapeutic advances
in medicine of the twentieth century. Within only a few years,
Grüntzig succeeded in developing an idea into a functional tech-
nical device, which allowed for the first time to expand a stenosed
artery from the lumen by applying pressure to a balloon located at
the catheter tip. First introduced in 1974 (22, 26), balloon angio-
plasty has since become the most frequently used treatment in
vascular emergencies of the heart and the peripheral circulation.
Grüntzig’s discovery mainly initiated the « Phase 3 » of treat-
ment of acute myocardial infarction as recently defined by Eugene
Braunwald, M.D. (« myocardial reperfusion », 1975-present) (27),
saving patients from death and disability. On the occasion of the
40th anniversary of Grüntzig’s invention, we will review the histori-
cal developments in medicine that led the way toward intraluminal
therapy and provide an overview of the stages of Grüntzig’s life that
were central in the development of his new method.
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ANDREAS GRÜNTZIG: PRE-WAR GERMANY, ARGENTINA,
AND EAST GERMANY
Andreas Grüntzig was born on a Sunday, June 25, 1939, in Dresden,
Germany (28), shortly before the Second World War. His parents
were Dr. Willmar Grüntzig (1902–1945), a chemist who also had
studied medicine, and Charlotte Grüntzig, née Zeugner (1907–
1995), a teacher. Shortly after Grüntzig was born, the family moved
to Rochlitz, a small historical town located between Dresden,
Leipzig, and Chemnitz (Figure 1). Grüntzig’s father, who served as
a meteorologist during the war, went missing just before the war
ended. Charlotte Grüntzig and her two sons left for Argentina in
1950 to live with their relatives, but returned to Leipzig, now East
Germany, in 1951 (28) because Charlotte Grüntzig insisted that an
excellent education was of utmost priority for her children (28).
Andreas Grüntzig and his brother Johannes entered high school
at the Thomasschule zu Leipzig (28), the oldest public classical
high school in Germany founded in 1212. In the early eigh-
teenth century, Johann-Sebastian Bach was the St. Thomas Cantor
and his children were pupils at the school, which gained world-
wide accolades for its Thomanerchor (St. Thomas Boys Choir).
Andreas Grüntzig graduated from the Thomasschule in 1957 with
highest honors. In 1958, with the intention to become a physi-
cian, Grüntzig escaped the country before the Communist DDR
government closed East Germany’s borders, to join his brother
Johannes at the University of Heidelberg, leaving his mother and
grandmother behind in East Germany (28).
DEVELOPMENTS TOWARD ENDOVASCULAR THERAPY
BETWEEN THE 1890s AND THE 1970s
The concept of repairing arterial blood vessels, including the inser-
tion of non-biological structures into the arterial lumen goes back
more than 100 years and was first applied by the French surgeon
and biologist Alexis Carrel, M.D. (1873–1944) (15, 18, 24). Carrel
was awarded the Nobel Prize in Physiology or Medicine in 1912 for
his work in vascular medicine, which he started as a young med-
ical student (18). In 1894, when French President Sadi Carnot, a
physicist, was assassinated by stabbing with a knife in the abdomen,
bleeding to death, Carrel argued that President Carnot could have
been saved if surgeons had been able to repair injured blood vessels
(18). Andreas Grüntzig’s intention and approach were similar to
those of Carrel, namely to repair injured blood vessels. However,
for Grüntzig’s approach injury originated from inside the ves-
sel, and it was the luminal obstruction caused by atherosclerotic
plaque that he intended to repair (29).
While surgical revascularization or amputation was available
for peripheral artery disease, there were no routine options for
patients with advanced coronary artery disease until May 9,
1967, when René Favaloro, M.D. (1923–2000) introduced aorto-
coronary bypass surgery (19–21, 25). In the 1950s, surgical coro-
nary endarterectomy («currettement») had been introduced. In
1958, the Swedish surgeon Åke Senning, M.D. (1915–2000), fur-
ther refined this method, using venous patches to seal coronary
arteries after removing coronary plaques by endarterectomy (30,
31). Coronary endarterectomy, however, did not become a stan-
dard treatment because “intimal stripping” was often associated
with complications, some of which also related to the surgical
FIGURE 1 | Portrait of Charlotte Grüntzig with Andreas (sitting) and
Johannes Grüntzig (right). The photograph is embossed by a mark of
Photostudio Th. Alfred Hahn in Chemnitz, Germany, where the photograph
was taken in 1942. Photograph reproduced with permission of Johannes
Grüntzig, M.D., Düsseldorf.
instruments used (32–35). Also in 1958, Senning invented the
first cardiac pacemaker (36–38). In 1961, Senning accepted the
Chair of Surgery at the University of Zurich and created the
first intensive care unit on the European continent (38); he
was going to play an essential role for Grüntzig’s success in the
1970s (36–39).
The first angiography of human arteries was performed on
January 17, 1896 by the physicist Eduard Haschek, Ph.D. (1875–
1947) and the physician Otto Th. Lindenthal, M.D (1872–1947)
at the Physics Institute of the University of Vienna (40). The
anatomist Julius Tandler, M.D. (1869–1936) had placed the hand
of a corpse at their disposal. The arterial vessels were filled
with Teichmann’s solution (iodine solution), a mixture of chalk,
cinnabar, and paraffin, and applying X-rays [“X-Strahlen”] with
an exposure time of 57 min resulted in the first angiogram (40).
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Angiography of peripheral arteries was introduced in 1924 in the
United States by Barney Brooks, M.D. (1884–1952) (41) and in
Portugal in 1927 by the neurologist António Egas Moniz, M.D.
(1875–1955) (42) who in 1949 received the Nobel Prize in Phys-
iology or Medicine. In 1929, his surgeon colleague, Reynaldo dos
Santos, M.D. (1880–1970), introduced arteriography (43) and
aortography (44).
Catheterization in humans was first performed by the Ger-
man physician Werner Forssmann, M.D. (1904–1979). In the late
summer of 1929, as a surgical resident at the age of 25 years and
only one year out of medical school, Forssmann performed right
heart catheterization on himself using a urinary catheter at a small
provincial hospital at Eberswalde (45). He subsequently lost his
job because he had disobeyed orders of the Department Chair
(45–47). For these most daring self-experiments, published by
Forssmann between 1929 and 1931 (45, 48, 49), he was awarded the
Nobel Prize in Medicine in Physiology or Medicine in 1956 hav-
ing pioneered cardiac catheterization (50). Forssmann shared the
prize with the French physician André F. Cournand, M.D. (1885–
1988) and his American colleague Dickinson W. Richards, M.D.
(1985–1973) (47, 50).
Roughly a decade after Forssmann had performed the first
human cardiac catheterization (Andreas Grüntzig had just been
born), the Cuban radiologist Pedro L. Fariñas, M.D. (1892–1951)
developed a catheter-based technique for arteriography of the
aorta by introducing an urethral catheter through an exposed
femoral artery, the results of which he published in 1941 dur-
ing the Second World War (51, 52). However, Fariñas’ method
required surgery.
Yet another decade later, a young resident at Karolinska Insti-
tutet in Stockholm by the name of Sven-Ivar Seldinger, M.D.
(1921–1998) was working on his doctorate thesis at the Depart-
ment of Radiology, trying to optimize the insertion of arterial
catheters into punctured arterial blood vessels. Seldinger found
that – inserting first a guide wire through the needle lumen into
the artery, then withdrawing the needle and subsequently inserting
a catheter of the same size as the needle via the guide wire – was a
fast, safe, and feasible method for arterial catheterization. He pub-
lished his new method, still known and used today as the Seldinger
technique, in 1953 (53). Ironically, his Department Chair deemed
this new approach to be insufficient for awarding Seldinger his
doctorate (54).
On October 30, 1958, F. Mason Sones, M.D. (1918–1985) at the
Cleveland Clinic inadvertently performed the first angiography of
a right coronary artery in a 26-year-old patient, establishing coro-
nary angiography as a diagnostic tool and for future developments
associated with it (55, 56). He first reported more than 50 cases
at the American Heart Association’s Scientific Sessions in 1959
(57). At about the same time, the young surgeon Thomas J. Foga-
rty, M.D. (born 1934), developed a balloon catheter for removing
emboli and thrombi from peripheral arteries (58). Fogarty pub-
lished the concept for his embolectomy balloon catheter in 1963
(59). The catheter was inserted by surgical arteriotomy, forwarded
through and behind the clot, the balloon inflated, and the clot
extracted (58). For over a decade, all catheters were hand-made
by Fogarty (an example that Grüntzig later would follow) before
becoming commercially available in 1969.
1964: CHARLES T. DOTTER AND PERCUTANEOUS
TRANSLUMINAL ANGIOPLASTY
Catheter-based percutaneous treatment of occlusive arterial dis-
ease had its origins with Charles T. Dotter, M.D. (1920–1985) in the
United States (59–63). The first transluminal angioplasty – like the
first coronary angiography by F. Mason Sones (55, 56) – was done
inadvertently in 1963 (64): while Dotter was performing a routine
abdominal aortogram in a patient with renal artery stenosis, he
inadvertently re-canalized a stenosed right iliac artery by passing a
catheter retrogradely into the occluded artery (64). Following an
invitation by Prague radiologist Josef Rösch, M.D. (born 1925),
with whom Dotter had been in contact for several years, Dotter
reported this accidental recanalization during his lecture “Car-
diac catheterization and angiographic techniques of the future”
(65, 66) presented on June 10, 1963 at the Congressus Radiologicus
Cechoslovacus held in Karlovy Vary (Karlsbad). Dotter closed his
lecture foreseeing the future use of his method:
«The angiographic catheter can be more than a tool for passive
means for diagnostic observation; used with imagination it can
become an important surgical instrument.» (65).
Rösch later accepted Dotter’s invitation to spend a fellowship at the
University of Oregon in Portland, OR, USA, and left Czechoslo-
vakia in March of 1967, only one year before Warsaw Pact troops
and tanks occupied his country. Josef Rösch remains active to this
day at the Dotter Interventional Institute, established in 1990 at
the University of Oregon in the honor of Charles T. Dotter, M.D.
At the time, Melvin P. Judkins, M.D. (1922–1985) had joined
Dotter as a radiology fellow at the age of 39 years after having
spent more than a decade as a family physician (67). Only shortly
thereafter, he would introduce the transfemoral access for car-
diac catheterization (67, 68), which would become the standard
access route for cardiac catheterization for many decades (67). Six
months after his lecture in Karlovy Vary, Dotter and his trainee
Judkins performed the first intentional transluminal angioplasty:
the patient Dotter had selected was an 83-year-old lady by the
name of Laura Shaw (Figure 2) (60, 63, 67, 69), bedridden for
months with a cold, painful left leg, and admitted for amputation
due to progressive gangrene. A poor run-off arteriogram and the
patient’s general condition were thought to contraindicate recon-
structive surgery and the patient also refused surgical amputation
of her foot (70). After diagnostic angiography on January 6, 1964
had revealed a tight stenosis of the distal superficial artery (60), on
January 16, 1964 at 2 p.m., a co-axial catheter system (consisting of
a tapered 8 and 12 Fr Teflon® catheter) was introduced to dilate the
stenotic area (Figure 2) (60). The angioplasty procedure was suc-
cessful, the gangrene healed, and the artery remained open until
the patient’s death from heart failure 3 years later. Dotter’s hand-
written notes on the first percutaneous transluminal angioplasty
(PTA) procedure and the typed report are shown in Figure 3.
Dotter published the results of the first patient cases together
with Judkins in the same year, and in their article specified further
the possible future use of his new method in coronary and renal
arteries, at the time applied only to peripheral arteries.
«Transluminal recanalization appears quite applicable to other
arterial systems, particularly those smaller than are usually con-
sidered suitable for conventional reconstructive arterial surgery.
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FIGURE 2 |Top: Angiograms of the first intentional percutaneous
transluminal angioplasty (PTA) performed on January 16, 1964 by Charles T.
Dotter, M.D. and Melvin P. Judkins, M.D., in patient Laura Shaw. (A) The
initial control angiogram reveals a tight, thread-like stenosis of the left distal
superficial femoral artery. (B) Angiogram of the same artery immediately
after the angioplasty procedure, which was performed using a 3.2 mm
co-axial catheter (C) Follow-up angiogram of the same artery 3 weeks after
the PTA procedure demonstrates luminal patency, indicating successful
angioplasty. Bottom: Charles Dotter’s first angioplasty patient, 83-year-old
Laura Shaw in February 1964 three weeks after the first PTA. The patient
holds the radiographic films with the same three angiograms shown in the
top panel of this figure. Top figure reproduced from Dotter and Judkins (60),
with permission of the American Heart Association. Bottom figure
reproduced with permission of the Dotter Interventional Institute, Oregon
Health and Science University, Portland, OR, USA.
If its use in femoral disease can be taken as an indication, severe
proximal narrowing of the coronary artery will be amenable
to a manually guided dilator inserted via aortotomy or via
the brachial artery by the Sones technic. Proximal stenosis of
the renal, carotid, and vertebral arteries appears suitable for
transvascular treatment.» (60)
Importantly, in his article Dotter already describes in detail the
concept of an expandable (dilator/balloon) catheter (“hydraulic
dilatation”), which he was developing at the time (60). Dotter
mentioned to his patients that he was working on this new
catheter, and one patient also reported in his article is quoted
that he “anxiously awaits the development of the dilating catheter-
probe” (60).
«In order to improve the technic, a major instrumental design
effort is underway. It consists of the development of a device
suitable for percutaneous insertion, which is a functional equiv-
alent of the present spring guide but capable of externally
controlled concentric expansion over a suitable portion of its
length. Expansion from an initial OD [outer diameter] of 0.05
to a final OD of 0.2 inch would be desirable. This, it is hoped, will
minimize the possibility of inadvertent dislodgement of athero-
matous fragments, since the dilator will be positioned in the
form of a thin, flexible guide, prior to providing forceful, local
expansion as needed.» (60).
Finally, Dotter presents the concept later to be known as coro-
nary stenting, which at the time he referred to as «endovascular
splint», and describes re-endothelialization as “re-intimalization”
as the essential regulatory role of vascular endothelial cells in
atherosclerosis (8, 9, 71) was unknown at the time.
«Once a pathway has been created across an occluded segment,
repeated dilatation or the temporary use of a silastic endovas-
cular (or, in some cases, paravascular) splint could maintain an
adequate false lumen until the natural process of fibrosis and re-
intimalization had taken place. We believe re-intimalization is
as likely to occur on the walls of a lumen formed by the patient’s
own tissues as on the fibers of plastic prosthesis» (60)
Only one year later, in 1965, Dotter dilated a stenosed iliac artery
using an embolectomy balloon developed by Thomas J. Fogarty
(72), but concluded that the compliant balloon was not suitable for
arterial dilatation and a more rigid one would be needed (64, 72).
Already half a century ago (69), Dotter realized the educational
value of film recordings (nowadays video recordings) (73). His
1968 training movie entitled “Transluminal Angioplasty” written,
directed, and narrated by Dotter himself on how to perform the
angioplasty procedure has been recently released on behalf of the
50th anniversary of its introduction to medicine (69, 73). This
movie was to play an important role in the friendship that later
developed between Dotter and Grüntzig and will be further dis-
cussed below. It is noteworthy that in this movie – like in his 1964
article pioneering angioplasty (60) – Dotter mentions the potential
future use of percutaneous transluminal angioplasty in coronary
arteries (73). Only 7 years later, Andreas Grüntzig at the Univer-
sity of Zürich would succeed in performing the first experimental
coronary balloon angioplasty on September 24, 1975 (74, 75). It
was Dotter’s vision and his new approaches that would become an
essential element for Andreas Grüntzig’s future work in vascular
medicine (76). Ironically, for their different inventive approaches,
Dotter and Grüntzig both received a nomination for the 1978
Nobel Prize in Medicine or Physiology (77). The nomination was
submitted by William T. Fowley, M.D (1912–1992), a renowned
New York vascular physician and clinical expert in the treatment
of atherosclerotic vascular disease (78).
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FIGURE 3 | Left: Case notes by Charles T. Dotter, M.D., hand-written on
January 16, 1964, after the first successful superficial femoral artery PTA was
performed in patient Laura Shaw. Right:The typed PTA intervention report of
January 21, 1964, signed by Dotter. Note: already in 1964 Dotter was using
the metric system to indicate lesion size, although in the article reported the
same year he was still using inches. Figure reproduced with permission of the
Dotter Interventional Institute, Oregon Health and Science University,
Portland, OR, USA.
ANDREAS GRÜNTZIG: PHYSICIAN AND POST-DOCTORAL
FELLOW IN HEIDELBERG AND LONDON
On April 8, 1964, Grüntzig graduated from medical school at the
University of Heidelberg and two years earlier had published his
first scientific article which included the data of his D.M. thesis on
ventilation effects on dead space changes (79). He wrote his thesis
under the supervision of Gotthard Schettler, M.D. (1917–1996),
one of Germany’s foremost atherosclerosis researchers at the time
(80). After completion of his internship (Medizinalassistenten-
zeit) in hospitals in Mannheim, Hannover, Bad Harzburg, and
Ludwigshafen, by the end of September 1966 Grüntzig returned
to his Alma Mater with the goal to pursue a career in public
health. Grüntzig’s mentor, former physiologist Hans Schäfer, M.D.
(1906–2000) and now Director of the newly founded Institute of
Social and Occupational Medicine at the University of Heidel-
berg, secured him a postdoctoral research fellowship, which also
included training in public health and statistics in London and was
supported by a scholarship of the Council of Europe (Europarat).
Grüntzig later recalled about his research in London:
«My basic training was in internal medicine. Part of this was
taken in London, where I studied the epidemiology of chronic
diseases with Geoffrey Rose and Donald Reid. I became partic-
ularly interested in atherosclerosis. Later, in 1969, I had the
opportunity to meet Dr. Zeitler, a radiologist at a hospital
for peripheral vascular disease (Aggertal-Klinik, Engelskirchen,
West Germany)» (81).
In London, Grüntzig worked under Czechoslovakia-born Walter
Holland, M.D. (born 1929) (82) at St. Thomas Hospital Med-
ical School, today part of King’s College London, UK, as well as
with Geoffrey A. Rose, M.D. (1925–1993) (83), and Donald Reid,
M.D. (1914–1977) (84) at the Department of Medical Statistics
and Epidemiology of the London School of Hygiene and Tropi-
cal Medicine and also completed course in clinical epidemiology
(28). Reid’s research was very much focused on atherosclerosis
and cardiovascular disease prevention (84), and through Reid
Grüntzig learned more about the essentials of scientific excellence,
as remembered by Rose (85):
«Donald Reid’s guiding principles, inculcated in his students,
were “to give meticulous care to detail; to know the strength
and limitations of one’s data; to form intuitive judgments and
then to test them by cold reason; to allow neither laziness nor
impatience to erode the determination to get it right; and in all
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these activities, to be guided by the human values of compassion,
integrity, and humility.”» (85)
In the manuscript of his unfinished autobiography, Grüntzig also
indicates that already in the 1960s, he became familiar with ath-
erosclerosis and coronary artery disease from an epidemiological
perspective:
«Three years were spent as a research fellow in the field of epi-
demiology studying coronary artery disease. I have no doubt
that these years dramatically influenced my the ability to incor-
porate angioplasty into a complex disease process. [. . .] I heard
Dr. Eberhard Zeitler speaking about peripheral recanaliza-
tion using Dotter’s method. [. . .] I remained very impressed
by this new and rather radical approach to the problem of
atherosclerosis» (86)
Grüntzig, who already published several scientific articles during
this time dealing mainly with coronary artery disease and its risk
factors (79, 87–95), finally decided to leave epidemiology research
and pursue a career in clinical medicine. The achievements of
his years in Heidelberg and London are summarized in Schäfer’s
assessment of Grützig’s work (96):
«Dr. Andreas Grüntzig was employed as a clinical fellow in the
Division of Experimental Occupational Physiology at the Insti-
tute of Social and Occupational Medicine of the University of
Heidelberg from September 25, 1966 until April 5, 1969. Dur-
ing this time, he was mainly involved in conducting studies for
the so-called “Heidelberger Studie”, i.e. organization and clin-
ical investigation of more than 1,000 workers, employees, and
clerks of the municipality of Heidelberg. He has processed and
analyzed these data with regard to certain aspects and particu-
larly studied the role of alcoholism. In addition, he has tested the
reliability of the questionnaires used in the entire study, inter-
preted clinical data, and performed statistical analyses together
with expert statisticians. He has obtained good knowledge of all
fields of epidemiological research, and has become acquainted
with the most relevant methods of research, both from studying
by himself and by attending various courses. He has spent four
weeks at the Institute of Demoscopic Research in Allensbach, he
worked four weeks with Professor Holland at the Institute for
Social Medicine at St. Thomas Hospital in London, completed
a course at the London School of Hygiene and Tropical Medi-
cine, which focused on methods of epidemiology and statistics,
and finally attended a symposium of the Deutsche Forschungs-
gemeinschaft which addressed key methodological questions of
epidemiology. [. . .]. Mister Grüntzig performed all tasks swiftly
and with energy, he has gained good knowledge of this area of
research, and also performed a literature review to prepare for a
study on cerebrovascular atherosclerosis, which, however, could
not be conducted due to external factors that had nothing to do
with Dr. Grüntzig.»
[«Dr. Andreas Grüntzig war vom 25.9.1966 bis 30.4.1969 an
der arbeitsphysiologisch-experiementellen Abteilung des Insti-
tuts für Sozial- und Arbeitsmedizin der Universität Heidelberg
als Assistenzarzt beschäftigt. Er hat in dieser Zeit vorwiegend
an der Durchführung der sogenannten “Heidelberger Studie”,
d.h. Organisation und Untersuchung von über 1000 Arbeit-
ern, Angestellten und Beamten der Stadtverwaltung Heidelberg
mitgewirkt. Er hat die dabei gewonnen Daten in Richtung
auf bestimmte Teilprobleme ausgewertet und insbesondere die
Frage des Alkoholismus geprüft. Er hat ferner von der gesamten
Studie die Zuverlässigkeit der Fragebögen geprüft, Befunde aus-
gewertet, und zusammen mit Fachstatistikern statistisch verar-
beitet. Er hat sich hierbei gute Kenntnisse auf dem gesamten
Gebiete epidemiologischer Forschungsmethoden erworben, hat
die wesentlichsten Methoden teils aus eigener Anschauung, teils
in verschiedenen Kursen kennengelernt. So war er vier Wochen
am Institut für Demoskopie in Allensbach, hat vier Wochen bei
Professor Holland am Institut für Sozialmedizin des St. Thomas
Hospitals in London gearbeitet, hat dann einen Kurs der London
School of Hygiene and Tropical Medicine, der sich auf Methoden
der Epidemiologie und Statistik erstreckte, absolviert und war
schliesslich auf einem Symposium der Deutschen Forschungs-
gemeinschaft über methodische Grundfragen der Epidomolgie.
[. . .] Herr Grüntzig hat die ihm übertragenen Aufgaben mit
Schwung und Energie angepackt und durchgeführt, hierbei eine
gute Kenntnis des Fachgebietes gewonnen, und sich auch für eine
Studie über Zereberalsklerose durch Literaturstudium vorbere-
itet, wobei leider die Durchführung dieser Studie aus äusseren
Gründen, die nichts mit Dr. Grüntzig zu tun hatten, nicht
zustande kam.»] (96)
Grüntzig started working as a clinical fellow on May 1, 1969 at
the Angiologische Klinik – Max Ratschow Klinik of the Städtische
Kliniken Darmstadt, Germany, an hospital specializing in vascular
medicine and lead until his death a few years earlier by the founder
of German angiology, Max Ratschow, M.D. (1904–1963) (97, 98).
At the Angiologische Klinik – Max Ratschow Klinik (today Max
Ratschow Klinik für Angiologie – Medizinische Klinik IV as part
of the Klinikum Darmstadt), Grüntzig became familiar with the
clinical picture of peripheral artery disease. It was at the Klinik
Max Ratschow where Grüntzig and Ernst Schneider, M.D. first
met (99). One of Grüntzig’s patients asked him whether it was
possible – instead of using drug treatment or undergoing complex
coronary bypass operations – to just “clean” his obstructed arter-
ies, like a plumber cleans tubes using wire brushes. Grüntzig found
this idea“fascinating ” (37, 96). According to Grüntzig’s own words
(96), this was the moment when he began to develop his first the-
ories about therapeutic vascular interventions. Unlike previously
reported (100, 101), Grüntzig performed his first angiographies
of peripheral arteries already in Darmstadt in 1969 (and not in
Zürich in 1971); in his training certificate issued on October 10,
1969, by the head of the angiology department, H. M. Hasse, M.D.
(96), Hasse attested Grüntzig:
«In addition, he learned angiographic techniques and with great
skill successfully performed angiographies of peripheral arteries,
aortographies, and phlebograpies. [. . .] In his work he demon-
strated agility and a quick mind. His good predisposition and
many interests qualify him for the medical profession and for
academic medicine in particular»
[“Darüber hinaus erlernte er die angiographische Technik und
führte mit Geschick zahlreiche Extremitäten-Angiographien,
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Aortographien und Phlebographien erfolgreich durch. [. . .] In
seinen Arbeiten bewies er Wendigkeit und schnelle Auffassung.
Seine guten Anlagen und seine vielseitgen Interessen befähi-
gen zum Arztberuf und zur wissenschaftlichen Laufbahn im
besonderen Masse.”] (96)
During this time, Grüntzig happened to attend an afternoon
meeting of lectures given by the «Frankfurter Angiologischer
Kreis» [«FrankfurtVascular Medicine Circle»], organized by Dieter
Gross, M.D., Wolfgang Rotter, M.D., and Klaus Breddin, M.D.,
some of Germany’s leading vascular physicians at the time (102).
During that afternoon, Eberhard Zeitler, M.D. (1930–2011), of
the Aggertal-Klinik in Engelskirchen, presented his experience and
clinical success using the new Dotter angioplasty procedure (103).
On his way from the meeting back to Darmstadt, Grüntzig asked
his department head H. M. Hasse, M.D. for permission to learn
more about the Dotter procedure that Zeitler had established at the
Aggertal-Klinik (102–104). Grüntzig later told Zeitler that Hasse
made it very clear to him that there wasn’t a chance:
«I will never allow this kind of technique to be practiced at my
hospital»
[“So eine Technik kommt mir nicht ins Haus”] (102).
Also in the manuscript of his unfinished autobiography, Grüntzig
recalls the Frankfurt meeting and Hasse’s response to his request:
«It was at this time that my chief invited me to attend an
afternoon meeting in Frankfurt. For the first time, I heard Dr.
Eberhard Zeitler speaking about peripheral recanalization using
Dotter’s method. I recall that my chief was very upset that some-
one would try to attack diseased arteries by forcing catheters into
areas of narrowing. He made it clear that he never wanted such
a treatment to take place in his hospital.» (86)
ANDREAS GRÜNTZIG: DEVELOPING VASCULAR MEDICINE
AT THE UNIVERSITY OF ZÜRICH
“I have dedicated my life to vascular disease”
Andreas Grüntzig, M.D. (1969)
During his medical studies in Heidelberg, Grüntzig had come
across «Differentialdiagnose Innerer Krankheiten», a widely popu-
lar internal medicine textbook written by Robert Hegglin, M.D.
(1907–1969). Hegglin, Editor-in-Chief of the journal Cardiology
from 1962–1969, was Director of the Medical Policlinic at the
Kantonspital of the University of Zürich and published his mono-
graph «Differentialdiagnose Innerer Krankheiten» between 1952
and 1969 in 11 editions, many of which were translated into
foreign languages (105). His successor, Walter Siegenthaler, M.D.
(1923–2010), would later continue its publication using Hegglin’s
original title, albeit publishing Hegglin’s book under his own name
(106). With his book, Hegglin’s followed an approach introduced
by William Osler, M.D. (1849–1919) who 60 years earlier had
also published an internal medicine monograph for medical stu-
dents and practicing physicians (107). Hegglin had trained under
Wilhelm Löffler, M.D. (1887–1972), who founded the journal Car-
diology in 1937 and was its Editor-in-Chief until 1962. Hegglin
FIGURE 4 | Photograph of Andreas Grüntzig taken in 1969 at the time
when he was recruited by Robert Hegglin, M.D., to join the Medical
Policlinic at the Kantonspital of the University of Zürich. Photograph
reproduced with permission of Ernst Schneider, M.D., Zürich.
dedicated his book to Löffler acknowledging him as his teacher
(105). Hegglin was known as an outstanding clinician and educa-
tor. He is still known today for the discovery of the May–Hegglin
anomaly and the Fanconi–Hegglin syndrome (108, 109). Grüntzig
became fascinated by Hegglin after reading and studying with his
book (105); he was determined to pursue his clinical training with
Hegglin and applied for a position as a clinical fellow (Figure 4).
When Hegglin invited Grüntzig for a personal interview in 1969,
he asked him about his future plans. Grüntzig’s response was clear
and determined: “I have dedicated my life to vascular disease” (99–
101). Hegglin hired Grüntzig who began working as a clinical
fellow in the same year. As there was no open position in Hegglin’s
Medical Policlinic, Grüntzig first worked in the recently founded
Division of Angiology lead by Alfred Bollinger, M.D. (born 1932).
Hegglin died unexpectedly in the same year of a ruptured aortic
aneurysm.
Bollinger soon recognized the exceptional professional quali-
ties of Grüntzig, who worked into the night to help Bollinger with
his research papers (99). Bollinger remembered:
«If I asked Andreas to write an article, I’d have it in ten days.
If I asked for revisions I’d have them in two. He was quick and
absolutely decisive”. [. . .] He was always very rigorous with these
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kinds of things in seeking reliability and reproducibility. He was
very exact and precise and concerned to make things statistically
relevant. I have never worked with anyone in medicine who had
the kind of inner fire that he had. It was unbelievable.» (99).
TRANSLATIONAL VASCULAR MEDICINE IN THE 1970s: THE
GRÜNTZIG BALLOON CATHETER
“. . . and refinements would probably be suggested by others
as well as us. What’s needed is a working beginning.
YOU OF ALL PEOPLE MUST KNOW HOW WIDE THE
GAP BETWEEN THE IDEA+ THE GADGET. IT’S THE
LATTER WHICH PAYS OFF.
I actually made heat-shrink, preformed sleeve balloons for
catheters once but I wasn’t professional or self confident.”
Charles T. Dotter, M.D.
In the 1960s, Charles T. Dotter, M.D. – as reflected by his above
quote from a communication with Bill Cook (69) – had also
experimented unsuccessfully with sleeve balloons. In fact, when
Fogarty was an intern at the University of Oregon in the 1960s,
Dotter asked Forgarty to make some balloons (110) and even once
used an embolectomy balloon to dilate an iliac artery (64, 72).
However, Dotter could not develop a sufficiently rigid balloon
catheter. To improve angioplasty of larger arteries, Dotter in 1966
had constructed a “reinforced balloon-dilating catheter” in which
a woven fiberglass sheath surrounded a simple balloon catheter
(70). Grüntzig knew also of studies done with so-called caged
balloon catheters («Korsett-Ballonkatheter») introduced in 1973
by Werner Porstmann, M.D. (1921–1982) in Berlin. This catheter
consisted of an 8-Fr outer Teflon® catheter with four longitudi-
nal slits. A latex balloon catheter inflated inside the slits permitted
dilation up to 9 mm, sufficient to treat iliac artery lesions, yet it did
not yield the expected results (111). Dotter improved Porstmann’s
device and used the “caged balloon-dilating catheter” for success-
ful treatment of iliac artery obstructions in 48 patients (112). Early
failure with thrombosis, however, limited the use of this dilating
catheter and neither of these balloon catheters ever found its way
into wider practice (70). Despite unsuccessful attempts of his col-
leagues, Grüntzig remained optimistic and was convinced that the
idea to apply defined pressure from the luminal side using an
inflatable balloon to the stenosed vascular wall would be the way
to make his idea work.
In 1971, after Grüntzig had moved to the Department of Radi-
ology of the University of Zürich working under Josef Wellauer,
M.D. (1919–1997), he was again able to perform arterial angiogra-
phies, which he had started 2 years earlier in Damstadt at the
Max Ratschow Klinik. Grüntzig also visited Zeitler at the Aggertal-
Klinik in Germany, where he familiarized himself with the Dotter
technique (28, 76). Grüntzig remembered:
«I not only observed the procedure itself during this time but
also saw the patients before and after treatment and when they
left the hospital. I was very impressed with the improvement in
peripheral ankle pressure as measured by ultrasound and by the
fact that the patient was able to walk without any claudication
after successful catheter treatment.» (86)
Grüntzig invited Zeitler back to Zürich to introduce the“dottering”
of occluded arteries (dilating arteries using the Dotter-catheter
technique, or “Dottern,” as the German physicians called it). In
the same year, on December 15, 1971, Grüntzig began performing
angioplasties using Dotter catheters in Zürich, the first of about
50 cases that would follow. Grüntzig published the results of the
first Dotter angioplasty studies in Zürich in 1973 (113).
1974: THE FIRST BALLOON ANGIOPLASTY AT THE
UNIVERSITY OF ZÜRICH
According to Grüntzig (22), the idea for the balloon catheter
was born during the same time when he began to use Dotter
catheters in Zürich, i.e., in late 1971. Within another 2 years after
his arrival in Zürich and without any support from the federal
funding agencies, working at home in the evenings and on week-
ends in addition to his full-time clinical duties, Grüntzig had suc-
ceeded in having functional, hand-made balloon catheters at his
disposal (22).
In October 1973, Grüntzig moved to the Division of Cardiol-
ogy of the Kantonspital’s Medical Policlinic, at the time headed
by Wilhelm Rutishauser, M.D., but continued doing angioplasty
procedures in patients at the University’s Department of Radiol-
ogy. Four months later – on February 12, 1974 – Grüntzig for
the first time successfully applied his new single-lumen dilating
catheter with a 4 mm balloon in his patient Fritz Ott, a 67-year-
old gentleman who had been admitted because of incapacitating
claudication caused by a severe femoral artery stenosis (99, 101).
Bollinger remembered how Grüntzig obtained informed consent
from his patient:
«In his kind and caring way, Andreas explained the therapeu-
tic principle to the patient during a full hour and obtained his
informed consent, long before ethical committees existed.» (99).
Grüntzig’s typed report of this first successful balloon angioplasty
and the angiographs of another early femoral artery balloon dilata-
tion performed in a 74-year-old patient a week later are shown in
Figure 5. Though Grüntzig refers to his balloon new device as“new
dilatation catheter” (neuer Dilatationskatheter), he described this
first balloon PTA procedure simply as “Dottern.” To indicate that
this was the first ever balloon dilatation, Grüntzig’s assistant Maria
Schlumpf in red ink at the time added to the report the word
“Dilatation” (Figure 5) to indicate that the procedure was differ-
ent from the regular Dotter-catheter procedures that Grüntzig was
also routinely doing at the time. Like Dotter’s first patient Laura
Shaw 10 years earlier (Figure 2), Grüntzig’s first patient Fritz Ott
was soon able to walk again free of pain (99–101).
Less than a month after the first femoral balloon angioplasty,
Grüntzig performed the first balloon angioplasty of an iliac artery
stenosis on March 6, 1974 using a shorter but wider balloon mea-
suring 8 mm in diameter (the tip of the original catheter used is
shown in Figure 6). Pre- and post-interventional angiograms of
this first iliac artery dilatation were included in the initial report
by Grüntzig and fellow German Heinrich Hopff, Ph.D. (1896–
1977) (22). The angiograms of Grüntzig’s first iliac artery balloon
angioplasties were re-published in our recent report in the Journal
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FIGURE 5 | Left: A copy of Grüntzig’s report written in German of the first
balloon angioplasty performed on February 12, 1974, utilizing his
hand-made, single-lumen balloon catheter. In this report, Grüntzig
describes “Dottern, linkes Bein” [Dottering, left leg], and summarizes the
procedure. Grüntzig refers to a “neuer Dehnungskatether” [new dilatation
catheter], which is the only hint that a balloon angioplasty was performed.
To specifically indicate this, Maria Schlumpf added “Dilation” in red ink
above the description of the procedure right after the typed report had
become available (39). Right: Femoral artery dilatation by Grüntzig
performed on February 19, 1974 using a single-lumen balloon catheter. (A)
Severe atherosclerotic disease resulting in several stenoses of the right
superficial femoral artery, note severe wall irregularities. (B) The same
artery after balloon dilation: Grüntzig described the PTA procedure as
follows: “We dilated the entire artery down to the knee. The step-by-step
dilatation of the superficial femoral artery resulted in a hemodynamically
sufficient lumen, but severe wall irregularities are visible after dilation. After
2 years the vessel lumen is completely clear. Since the intervention, the
patient has been symptom free.” (81) (C) In the dilated artery, patency was
confirmed two years later. Photographs reproduced with permission of
Maria Schlumpf, Zürich.
(26). Grüntzig described the first iliac artery balloon dilation as
follows:
«A 73-year-old male patient had hyperlipidemia, hypertension,
diabetes, and myocardial infractions with intermittent claudi-
cation of 500 m. He was considered a candidate for dilation. We
started the series of iliac dilations and used our new iliac dila-
tion catheter for the first time in March 1974, in this patient.
He became symptom free until the progression of disease in the
right femoral artery. The figure [lower panel (114)] shows the
compression of the atheroma against the medial site of the com-
mon iliac artery. The disease did not recur in the dilated segment
until 5 years later» (81).
Hopff was an expert in the chemistry of polyvinyl chloride
(PVC) and an emeritus professor of organic chemistry at the Fed-
eral Institute of Technology (ETH) in Zürich. Based on the results
of his research (114, 115), he suggested to Grüntzig to use PVC as
material of high rigidity that might be suitable for the use as a dilat-
ing balloon. In the manuscript of his unfinished autobiography,
Grüntzig describes meeting Hopff and his search for the ideal
balloon material:
«I spent the next two years contacting manufacturing plants
in an attempt to solve this problem. Especially fruitful was the
cooperation of a factory which produced shoelaces which pro-
vided me with silk meshes which I planned to wrap around the
balloon, thus limiting its outer diameter. I then needed a very
thin balloon to insert within the mesh. It was at that time that I
met a retired chemist, Dr. Hopff, a professor emeritus of chem-
istry [. . .]. He introduced me to polyvinyl chloride compounds.
I started to experiment with this material and studied his book
on organic chemistry. I acquired some small thin polyvinyl chlo-
ride material used as insulation for electrical wires. Following
the descriptions in his book [(115)], I heated a localized segment
of the tubing and applied compressed air pressure resulting in
a localized aneurysm of the tubing. I used a second outer tub-
ing measuring 4 mm in diameter to confine the diameter of the
segment. After hundreds of experiments, most of which were per-
formed in my own kitchen, I was able to form a sausage-shaped
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FIGURE 6 |Top: Photograph of the inflated, original balloon-dilating
catheter hand-made by Andreas Grüntzig, which he used for the first iliac
artery balloon angioplasty on March 6, 1974. For size comparison, a
centimeter tape measure is shown. Angiograms obtained during this PTA
procedure are available online in another article of the Journal (26).
Bottom: Part of the first page of the U.S. patent application by Andreas
Grüntzig and Hans Gleichner, also showing a cross-section drawing of the
balloon catheter, which resembles the original device shown in the upper
panel of this figure. Top photograph reproduced with permission of Ernst
Schneider, M.D., Zürich.
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FIGURE 7 | Left: Pre-, inter-, and post-interventional angiograms of
balloon PTA of an occluded left superficial femoral artery in a
63-year-old male patient, performed by Grüntzig and Mahler on
October 27, 1975. Right: A copy of the report summarizing the PTA
procedure of October 27, 1975. Femoral artery angiography
demonstrates an occluded segment measuring 18 mm in length.
Passage of the occlusion is difficult, but possible after changing to a
special catheter (gray Ödman catheter). The operator changes to the
balloon catheter [“Wechsel auf Dilatationskatheter”]; subsequently,
the occluded segment is dilated twice and blood flow successfully
restored. Photographs reproduced with permission of Maria Schlumpf,
Zürich.
distensible segment which I tried to reinforce with the silk mesh.
When I mounted the material on a normal catheter tubing and
applied pressure to distend the aneurysmal segment, I suddenly
realized that the strength of this material was so great that the
silk mesh was not necessary. This was a great breakthrough and
enabled me to reduce the size of the catheter.» (86)
Grüntzig and Hopff published the principle of the new balloon
catheter and reported the clinical findings from a series of the
first 15 patients successfully treated with balloon angioplasty (22,
26). We have recently discussed how the international recognition
of this method was delayed because the article was published in
German only (26). Grüntzig initially coined his technique “percu-
taneous transluminal dilatation” (116). In his habilitation thesis,
submitted to the University of Zürich in 1977 and qualifying
him for faculty rank, Grüntzig referred to his method as “per-
cutaneous transluminal recanalization” (116), a term previously
introduced by Dotter (60) and also used by others (117). For the
cover of his habilitation thesis, which he published as a book (116),
Grüntzig selected pre- and post-interventional angiograms of a
balloon catheter-treated femoral artery occlusion, which he suc-
cessfully re-opened on October 27, 1975, these angiograms are
shown in Figure 7. The Grüntzig balloon angioplasty procedure
became known as PTA or as “percutaneous transluminal coronary
angioplasty” (PTCA) in cardiology (118), with reference to the ter-
minology originally introduced by Dotter (60, 64, 73). Grüntzig
filed a patent application on the balloon catheter concept with the
U.S. Patent Office on November 21, 1977 (Figure 6) and simul-
taneously with patent offices in Switzerland, Germany, France,
England, and Japan (26), securing the rights to his intellectual
property of the balloon catheter principle (Figure 8). The bottom
panel of Figure 8 shows the first balloon catheter ever made by
Grüntzig at a stage when it was not yet intended for patient use.
BACK INTO THE FUTURE: PERSONALIZED MEDICINE IN THE
1970s
For the next two and a half years, each balloon catheter would be
custom-made for each individual patient on the Grüntzig kitchen
table (Figure 9) (36). Prior to the PTA procedure, Grüntzig would
obtain a native angiogram, take it home, measure the arterial
lumen and length and width of the stenosis from the angiogram,
calculate the optimal diameter and length of the balloon needed,
and build a balloon to fit that particular stenosis (39); he would
accomplish this together with his assistant Maria Schlumpf and
the help of their spouses, Michaela Grüntzig and Walter Schlumpf.
Thus, there was «personalized medicine» already in the early 1970s.
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FIGURE 8 |Top: the Grüntzig balloon catheter principle. The double-lumen
dilatation catheter (120) now contains a main lumen and an additional
lumen. The main lumen allows insertion of the guide wire, pressure
measurements, and injection of contrast dye. The balloon segment at the
catheter tip can be positioned in the stenosed or occluded vascular
segment and is filled with liquid via the additional lumen. By applying an
equally distributed and constant pressure between 4 and 6 atmospheres,
the atherosclerotic plaque occluding the artery is pressed against the
vessel wall for 10–30 s. The maximum diameter of the inflated balloon is
4 mm for femoral arteries and 8 mm for iliac arteries. Once the balloon is
deflated, the newly formed vascular lumen opens, and blood flow is
restored. In its deflated form, the balloon will adhere to the catheter like an
umbrella and can be pulled back, and the procedure is completed. Figure
legend and drawing according to a sketch by Andreas Grüntzig (36).
Bottom: the very first balloon catheter constructed by Grüntzig in 1971,
long before balloon catheters were fully functional for the use in patients.
The tip of this single-lumen catheter was sealed to allow inflation and
extension of the balloon, which was glued and fixed on both sides with a
thread onto the catheter tube. Balloons were fixed with surgical sutures to
all hand-made catheters until mid-1975 when Cook and later the Schneider
company began manufacturing Grüntzig balloon catheters. Photographs
reproduced with permission of Maria Schlumpf, Zürich.
The first single-lumen balloon catheters (used until January 1975)
were red “Ödmans” [catheters], in which little holes were cut using
razor blades in those portions of the catheter where the balloon
was to be inflated. The PVC balloon tube was glued to the catheter
and both ends were fixed with a fine thread; the knots of the
threads tying the balloon tube to the catheter were always done
by Grüntzig himself, who would justify this with his surgical skills
being the only physician on the team (39). All balloon catheters
FIGURE 9 |Top: Maria Schlumpf at the Grüntzig kitchen table sorting out
materials used for building the hand-made balloon catheters. Catheters
were built by both of them with the help of their spouses Michaela Grüntzig
and Walter Schlumpf. Photograph ca. 1975. Bottom: Andreas Grüntzig and
Pierre Levis in Atlanta, GA, USA, during the 1981 angioplasty course held at
Emory University. Photographs reproduced with permission of Maria
Schlumpf, Zürich.
were used only once, and until the second half of 1976, when
the Schneider company was founded and began to manufacture
Grüntzig’s balloon catheters, every catheter used for balloon angio-
plasty procedures in Zürich was a hand-made, custom-built device
manufactured in the evenings and on weekends (36) (Figure 9).
1977: THE FIRST CORONARY BALLOON ANGIOPLASTY
Soon, Grüntzig would develop a double-lumen catheter allow-
ing greater versatility and better handling than single-lumen
devices, and he commissioned engineer Helmuth Schmid to
add a second groove into the red Ödman catheters (39). The
first femoral angioplasty using a double-lumen balloon catheter
was performed on January 23, 1975 (119), and Grüntzig pub-
lished his experience with this new device in 1976 (120)
(Figure 10); ironically, the article abstract does not mention
the word “balloon” but only describes the new double-lumen
balloon catheter as “a modification of Dotter’s transluminal
recanalization of stenoses and occlusions” (120). Grüntzig was
now able to apply equal, constant and defined pressure to the
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FIGURE 10 |Top: A double-lumen catheter for iliac artery balloon
angioplasty, connected to a three port stop-cock, with one port connected
to a syringe containing liquid to inflate the distensible balloon portion of the
catheter. Tape measure indicates centimeters. Bottom: Hand-made
double-lumen balloon catheters assembled by Grüntzig and his associates
on his kitchen table shown in Figure 9. Shown on the left is an inflated iliac
artery balloon catheter (with a similar, deflated catheter to its right) and an
inflated femoral artery catheter (with a similar, deflated catheter to its right).
Note that the balloons are tied to the catheters with fine surgical threads
and that catheter tips have been conically tapered, which was done by hand
using sandpaper. Inflated balloon diameter of femoral catheters is 4 and
8 mm in iliac artery catheters. Tape measure indicates centimeters.
Photographs reproduced with permission of Maria Schlumpf, Zürich.
vascular wall (Figure 8) as he had planned in 1971. While
Grüntzig continued to treat patients with peripheral vascular
disease using new, double-lumen balloon catheters (Figure 10),
he also started to explore other vascular territories. In 1974,
Grüntzig began developing and experimenting with catheters of
reduced diameter that would allow their use in coronary arteries
(Figure 11).
Grüntzig was aware that others, including Dotter – who already
mentioned the coronary circulation as a potential target for angio-
plasty in his 1964 article (60), had thought of a broader application
of angioplasty including the coronary arteries, and specifically
acknowledged Dotter’s pioneering role in the field (29). Grüntzig
remembered:
«My background in internal medicine was most helpful in help-
ing me follow the patient’s progress clinically. At that time it was
my intention to become a cardiologist and I began to consider
application of the technique to the heart. I designed a prospective
follow-up study of the patients treated with the Dotter tech-
nique with regular examinations every three months after the
procedure in order to begin assessing the long-term patency of
these patients. The early results were favorable but from the
very beginning I realized the problems and limitations of Dot-
ter’s technique. Everyone involved in the method at that time,
including Charles Dotter, realized that any application of the
dilatation procedure to other areas of the body would require
technical changes.» (86)
In Zürich, the cardiac surgeon Åke Senning (36, 38, 39) – unlike
Siegenthaler, Krayenbühl, or the surgeon Hans-Ulrich Buff (38) –
fully supported and actively helped Grüntzig to proceed with his
plans. In fact, when Grüntzig approached him asking whether he
could count on his support, Senning responded:
«Mr. Grüntzig, you will be taking away my patients, but get
started right away!»
[«Herr Grüntzig, Sie werden mir die Patienten wegnehmen,
aber legen sie los!»] (38)
With Senning’s support, Grüntzig began testing smaller balloon
catheters for coronary arteries (Figure 11) in large animals (36,
121, 122) and human cadavers, with the help of his Swiss assis-
tant, Maria Schlumpf, and the Croation cardiac surgeon Marco
Turina, M.D. (born 1937) (122), and others. Turina, who at the
time Senning had commissioned to perform the cardiac surgery
in the experimental studies (74), remembers Grüntzig:
«He had the ‘sacred fire’, as the French call it. It was what
he thought about constantly. I have never seen somebody so
centered on a single idea like Andreas was. Never in my life.
Everyone was telling him his idea would never work, and had
been tried before, and that he was going to fail, that there were
pitfalls at every turn. But the idea was consuming him all the
time.» (99).
Grüntzig’s younger daughter Sonja, who recalls having her meals
at the same kitchen table that the catheters were made on, joked
about herself being a “twin” of the Grüntzig balloon catheter, as
her father was completely absorbed with making his idea work
(123).
Grüntzig began to evaluate new, more refined and thinner
coronary balloon catheters in canine coronary arteries (74, 121,
122) in which the surgeons had experimentally induced coronary
stenoses (Figure 11). The first balloon dilatation of a coronary
artery was performed in Zürich on September 24, 1975 (119). The
data from these experiments – demonstrating the feasibility and
efficacy of this approach – were presented at the Spring meet-
ing of the Deutsche Gesellschaft für Kreislaufforschung (today
Deutsche Gesellschaft für Kardiologie, DGK) in Bad Nauheim,
Germany, in April 1976 (74), as well as at the American Heart
Association’s Scientific Sessions in Miami, FL, USA, November
15–18, 1976 (124) (Figure 11). Given the success of coronary
balloon angioplasty in his experimental studies, Grüntzig was
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FIGURE 11 | Left: Schematic representation of the coronary double-lumen
balloon dilatation catheter used for PTCA procedures of stenosed canine
coronary arteries, which Grüntzig published in 1976 (74, 121, 124). The
preformed guiding catheter is sealed by an adaptor against the dilatation
catheter localized inside. The main channel of the double-lumen catheter is
connected to a three port stop-cock, which can be used to either measure
coronary pressure, to inject contrast dye, or to perfuse the coronary artery
with arterialized blood. Connected to the neighboring channel of the dilatation
catheter is a syringe, which is used to inflate the distensible segment of the
dilatation catheter. Pressure is applied by filling the distensible segment,
which exhibits only minimal compliance. To demonstrate perfusion with
arterialized blood, contrast dye was injected via the main channel, resulting in
visible filling of the circumflex branch of the left coronary artery. Additional
catheters positioned in the left ventricle and the aorta are also connected to
the central recording unit. AoP, aortic pressure; ECG, electrocardiogram; CoP,
distal coronary artery pressure; LCA, left coronary artery; LVP, left ventricular
pressure. Right: Grüntzig’s notes taken by the nurse assisting him with the
first coronary balloon angioplasty performed a conscious, awake patient on
September 16, 1977, in Zürich, Switzerland. Four months earlier, Grüntzig had
already performed several coronary balloon angioplasties after coronary
arteriotomy during open heart surgery together with Richard K. Myler, M.D.
and Elias Hanna, M.D. at St. Mary’s Medical Center in San Francisco. At the
bottom of the note, there is a small drawing of the aortic root with the
coronary arteries, indicating with an arrow the portion of the proximal LAD
where Grüntzig performed what he refers to as the first “Coronar-Dotter,”
paying tribute to the inventor of endovascular therapy. On this note, the
catheter used for the procedure is referred to as “Coronar-Dotter-Kath. nach
Grüntzig” [“Coronar-Dotter catheter according to Grüntzig”]. Left photograph
reproduced with permission of Maria Schlumpf, Zürich, right photograph
reproduced with permission of Ernst Schneider, M.D., Zürich.
determined to test its feasibility in coronary artery disease patients
(99, 116). Only now, having successfully completed translational
research that had already resulted in a new, non-surgical treatment
of occluded peripheral arteries and established coronary angio-
plasty in experimental studies (74, 121, 122), Grüntzig applied
for research funding from the Swiss National Science Founda-
tion (SNSF). Within the next 4 years, he was awarded three SNSF
research grants as Principal Investigator (125–127).
As the first successful renal angioplasty had been performed
by Zeitler at the Aggertal-Klinik in 1970, using co-axial Dot-
ter catheters (29, 128), Grüntzig also began to explore this
vascular territory. In Zürich, on February 2, 1977, Grüntzig
for the first time inserted his balloon catheter into a stenosed
human renal artery, and into a human coronary artery on
February 16, 1977; in both cases, Grüntzig did not perform
angioplasty (39). In December 1977, Grüntzig at the Univer-
sity of Zürich (29) and Mahler at the University of Bern (129)
performed the first renal artery PTA using Grüntzig balloon
catheters.
On March 22, 1977, Grüntzig was called to explore the fea-
sibility of his new coronary balloon catheter for percutaneous
transluminal coronary angioplasty (PTCA) a patient with severe
multi-vessel coronary artery disease, including a left main stenosis,
which the surgeons deemed inoperable. He failed to gain femoral
access – an approach pioneered by Melvin P. Judkins, M.D. in
1967 at the University of Oregon (67, 68) – trying to reach the
coronary artery ostium using a brachial access. Grüntzig recalled
the first PTCA attempt in humans, already here stressing the issue
of patient safety:
«The first patient on whom we attempted dilatation was a case
in which coronary vascular surgery was denied. The patient with
unstable angina, multivessel disease, mainstem stenosis, referred
to the coronary care unit, was presented to me and everyone
assured me that attempted dilatation with success would be the
proof for the efficacy of this method. I agreed, eager to enter
the area of competition with the surgeons. Unfortunately the
patient was so diseased that every attempt to puncture the groin
arteries failed because of total closures; only the left brachial
artery had positive flow to allow the passage of the catheter to
the aorta. With this entrance, the catheters were unable to guide
the coronary dilatation catheter to the orifice of the left main so
that we had to abandon the procedure. The patient died several
days after the procedure of a final myocardial infarction. The
case taught me that if you start a method, you should start with
an ideal case and not with end stage disease and this has been
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the truth for so many other colleagues being in a similar position
later in time.» (86, 130)
As the application of the new technique to human coronary arter-
ies would be challenging and in order to allow development of
the PTCA procedure in a safe manner, Grüntzig insisted PTCA to
be performed during bypass surgery so that patients would not
be jeopardized (131). In the manuscript of his unfinished and
unpublished autobiography, Grüntzig wrote in 1985:
«The next step was to demonstrate the technique in intra-
operative dilation. Cardiac surgeons in Zurich resisted the appli-
cation of intra-operative dilatation because they feared that
retrograde dilatation of the underlying stenosis in the native
coronary artery would create a competition in blood-flow to
the vein graft therefore resulting in closure of the graft. They
contended that the long-term patency of the dilated native coro-
nary stenosis was unknown and therefore presented a risk to the
patient.» (86)
Thus, Grüntzig began looking elsewhere. Within a short time,
Richard K. Myler, M.D. (1936–2013) and Grüntzig convinced Elias
Hanna, M.D. (born 1936) (132), a cardiac surgeon at St. Mary’s
Hospital in San Francisco, to assist them with this endeavor (131).
Grüntzig remembered:
«Dr. Elias Hanna, a surgical colleague working with Richard
Myler in San Francisco, did not have this fear. Dr. Hanna indi-
cated that his bypass grafts would ‘always be better than what
was accomplished with dilatation.’» (86)
On May 9, 1977, Grüntzig, with the assistance of Myler performed
the first of a number of coronary balloon angioplasties in anes-
thetized patients during coronary bypass surgery (28, 133, 134)
by retrograde insertion into a stenosed coronary artery after arte-
riotomy. Several coronary balloon angioplasties were done from
the opened thorax, and all dilations were done before the sur-
geons established the aorto-coronary bypass (135). Myler also
visited Grüntzig in Zürich (Figure 12) and became a close friend
(136–138).
Four months after the first intra-operative coronary angioplas-
ties in San Francisco, and only because Grüntzig had Senning’s
unreserved support (36, 38, 39), Grüntzig successfully performed
the first PTCA in Zürich in a conscious patient – 38-year old
Adolf Bachmann – who had been originally scheduled for bypass
surgery because of an isolated LAD stenosis [reviewed in Ref. (28,
131, 133, 135, 139–142)]. The nurse assisting Grüntzig took his
notes during the procedure. In his notes, the coronary artery bal-
loon dilatation is referred to as “Coronar-Dotter” (Figure 11) and
the balloon device as “Coronar-Dotter Kath[eter] nach Grüntzig ”
[Coronary Dotter catheter according to Grüntzig ], paying tribute
to Dotter who had opened this field more than a decade earlier
(Figure 11). Indeed, others (and Grüntzig himself) referred to the
balloon catheter as the“Grüntzig balloon catheter”(139, 143–146),
which subsequently was also utilized for intra-operative translu-
minal coronary angioplasty (72, 147, 148), for dilating recoarcta-
tion of the aorta (149), and for non-cardiovascular applications
such as dilation of bronchial stenoses (150, 151), or biliary (152)
or ileocolonic strictures (153). Interestingly, the idea of apply-
ing “angioplasty” to re-open obstructed nasolacrimal ducts had
FIGURE 12 | Left: Andreas Grüntzig on his Italian Piaggio Vespa scooter in
Zürich. Sitting in the front is Richard K. Myler, M.D. with whom Andreas
Grüntzig performed the first coronary angioplasties intra-operatively during
coronary bypass surgery in May of 1977 in San Francisco. Grüntzig kept this
photograph framed on his office desk at Emory University until his death.
Shown standing in the back is Simon H. Stertzer, M.D. Right: Andreas
Grüntzig during discussion with a course attendee of one of the angioplasty
demonstration courses held at Emory University, Atlanta, GA, USA.
Photographs reproduced with permission of Ernst Schneider, M.D., Zürich.
been introduced already in the 1940 (154), and is now done using
Grüntzig balloon catheters (155–158).
Grüntzig published the results of coronary balloon angioplasty
as a preliminary report in the Lancet in 1978 (124). He pub-
lished the results of a larger number of patient cases together with
Senning a year later (75).
The success and acceptance of coronary balloon angioplasty
in the field was by no means immediate. Grüntzig had only been
able to perform the first coronary balloon angioplasty because he
had the full support of Senning, who during a conference meeting
at the hospital in Zürich with surgeons and internists attending
cleared the way for Grüntzig with his famous quote (36, 100, 101):
«Mister Grüntzig: Do it, if something happens, I will operate»
[«Herr Grüntzig: Machen Sie es, falls etwas passiert, operiere
ich!»].
As a cardiac surgeon, Senning was well aware of the potential
risks that might be associated with the very delicate procedure
in small-lumen arteries. By April 1979, Grüntzig had treated 60
patients applying PTCA, 6 of whom had to undergo emergency
bypass surgery to prevent a major myocardial infarction (some of
them requiring reanimation) (29, 159); a small percentage of these
patients experienced a myocardial infarction; however, according
to Turina all these patients survived the PTCA or the surgical pro-
cedure. By April 1979, Grüntzig reported a primary success of
PTCA in 41 out of 60 patients; in 8 of these patients Grüntzig
performed balloon angioplasty in stenosed aorto-coronary bypass
grafts (29): at that time, PTCA had been successfully applied by
Richard K. Myler, M.D. in San Francisco (43 patients), Simon
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H. Stertzer, M.D. in New York City (43 patients), and Martin
Kaltenbach, M.D., in Frankfurt (16 patients) (29).
Grüntzig’s home institution continued to be hesitant to let him
proceed with the PTCA procedure. The skepticism and resistance
toward Grüntzig’s new approach expressed by his superiors in
Zürich, Siegenthaler and Krayenbühl (38), is also reflected by the
fact that Grüntzig had to wait for more than 2 months to have a
second patient referred for this procedure after his first successful
PTCA (122). As a consequence, 65 out of the 169 patients who
underwent PTCA in Zürich came from abroad [the 8th PTCA
patient was an American (160)]. In fact, even for the initial report
of the first PTCA cases of published in the Lancet in February 1978
(161), two of the five reported PTCA procedures had to be done by
Grüntzig at the University of Frankfurt (122) with the assistance
of Martin Kaltenbach, M.D. (born 1928). Among the first 12 cases,
PTCA was initially successful/possible in only 8 of them (39).
In the 1960s, Swiss cardiologist Paul R. Lichtlen, M.D. (1929–
2005) spent a fellowship with Richard S. Ross, M.D. (born 1924)
at Johns Hopkins University in Baltimore who was introduced
to coronary angiography by F. Mason Sones, M.D. at the Cleve-
land Clinic in the 1950s (162–164). Lichtlen helped to establish
coronary angiography in Zürich and subsequently in Europe. In
1972,Grüntzig together with Lichtlen published an article in which
the diagnostic sensitivity of a patient questionnaire was compared
with coronary angiography as the reference standard for diag-
nosing coronary artery disease (4). Lichtlen moved to Hannover
Medical School in 1973.
Though Lichtlen had recommended the SNSF to fund
Grüntzig’s grant application to further develop the clinical devel-
opment of PTCA (39), he remained cautious about the PTCA
procedure. Grüntzig’s first poster on experimental coronary angio-
plasty (124) presented at the 49th Scientific Sessions of the Ameri-
can Heart Association in Miami in November 1976 had caught the
eye of Lichtlen who mentioned it to Emory cardiologist, Spencer
King, M.D.:
You must see the exhibit by this man from Zurich in the next
aisle. (135, 165).
On February 8, 1978, 4 days after Grüntzig’s report of the first
five PTCA patients cases had appeared in the Lancet (161), the
Zürich Newspaper “Tages-Anzeiger” published a front-page arti-
cle, showing a photo of Grüntzig and Siegenthaler with the
headline “Zürich’s important contribution to fighting myocardial
infarction” [“Zürichs wichtiger Beitrag zur Bekämpfung des Herzin-
farkts”] (166). The article was followed by a press conference that
was broadcasted by the Swiss national television (SRF) (28). Less
than a week after the press conference and after also local Ger-
man newspapers had praised the new procedure as hope for heart
disease patients, on February 13, 1978, Lichtlen wrote a personal
letter to Siegenthaler, with copy to Senning and Grüntzig (39):
«. . .I consider your approach of informing the public at the
present state of this technique with only 10 treated cases und
unknown long-term results as very premature and therefore of
most questionable value. Hopes which currently by no means
can be fulfilled were created among many patients . . .»
[“. . . Ich halte dieses Vorgehen der Information der
Öffentlichkeit im jetzigen Stadium dieser Technik bei lediglich
10 behandelten Fällen und noch völlige unbekannten Lanzeitre-
sultaten für stark verfrüht und damit von sehr zweifelhaften
Wert. Es wurden dadurch bei vielen Patienten Hoffnungen
erweckt, die in keiner Weise zur Zeit zu erfüllen sind. . .”] (39).
Fortunately, time would tell that Lichtlen’s concerns were not
justified.
ANDREAS GRÜNTZIG: CLINICAL TEACHER AND EDUCATOR
IN VASCULAR MEDICINE
Following the success of the PTCA, cardiology and vascular medi-
cine colleagues came to Zurich hoping that Grüntzig would teach
them the new method. These teaching requests became so time-
consuming that he could no longer accomplish his daily clinical
routine as full-time attending physician at the cardiology division
of the Medical Policlinic. Grüntzig therefore decided to start live
demonstration courses at the Zurich Kantonsspital performing
balloon angioplasty with patients in the catheterization labora-
tory (28, 36, 133) (Figures 13 and 14). Grüntzig held four live
demonstration courses in Zürich between 1978 and 1980 (167), all
attended by cardiologists and vascular physicians from around the
world. During the first course held on August 7–10, 1978, and with
28 physicians attending, Grüntzig performed 7 PTCAs, 2 femoral
PTAs, and 1 renal artery PTA (39). While the first two courses (the
second counted 97 attendees) were held in the historical build-
ing of the hospital, the third and fourth course accommodating
171 and 221 attendees, respectively, were held in the newly built,
large lecture hall (Grosser Hörsaal Nord, Figure 13 bottom and
Figure 15). Grüntzig transmitted live from the catheterization lab-
oratory discussing with the audience while being with the patient
who was undergoing the angioplasty procedure. Ironically, accord-
ing to Grüntzig, it was during these live demonstration courses that
he learned the most from the comments and questions of his peers
(36, 39). Grüntzig enjoyed direct discussion with course atten-
dees during breaks from the angioplasty procedures that he did in
the catheterization laboratory (Figure 13), and was considered an
extraordinarily gifted teacher by his peers (76, 138, 165, 167).
Although the PTCA method had just been introduced into clin-
ical practice, Grüntzig did not consider this a problem and, accord-
ing to his former assistant Maria Schlumpf, he was convinced of its
safety when performed correctly (36). In fact, Grüntzig was always
and first and foremost concerned with the safety of the patient, and
initially thought – perhaps because 1 out of 10 patients underwent
emergency surgical revascularization in the early years (159) – that
only 5–10% of all coronary artery disease patients might be eligi-
ble to be treated with his new method. Grüntzig summarized his
experience from teaching in the early PTCA courses as follows:
«But it was the first course in Zürich with the critical audience
observing the performance in the very early state of my learning
curve which took the most. When I was asked why I chose to
perform in that way at the early stage, my answer was: ‘If the
method is good, it should work even in a live demonstration.
If not, let’s look at it before we endanger our patients!’. It was
this type of teaching which directly confronted a critical as well
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FIGURE 13 | Photographs of Andreas Grüntzig in the late 1970 during the
balloon angioplasty courses at the University of Zürich.Top: Grüntzig in the
catheterization laboratory of the Medical Policlinic during a PTCA procedure
at the Kantonspital, which was transmitted live into the lecture hall.
Bottom: Grüntzig discussing with course attendees in the lecture hall
(Grosser Hörsaal Nord, Figure 15) during the 1980 balloon angioplasty
course. Shown standing next to blackboard is Richard K. Myler, M.D.
Photographs reproduced with permission of Maria Schlumpf, Zürich.
as an enthusiastic audience with the truth and which helped a
great deal in teaching and spelling out the method» (39)
Grüntzig repeatedly emphasized that avoiding complications and
ensuring patient safety has utmost priority when selecting patients
for coronary balloon angioplasty.
1980: LEAVING ZÜRICH
His home institution and his superiors were unwilling to provide
Grüntzig with the needed support despite the overwhelming suc-
cess of his new treatment (36, 119, 165). Former colleagues of
Grüntzig at the Kantonspital in Zürich described the atmosphere
at the time unlike that in the United States:
«The US environment showed a different attitude to young doc-
tors [. . .] In Zürich, you were nobody unless you were a Professor
and it was very hierarchical.» (168).
FIGURE 14 | Photograph of the hands of Andreas Grüntzig during a
PTCA procedure in the catheterization laboratory during the 1979
angioplasty course held in Zürich. The procedure was transmitted live
and shown on screens located in the lecture hall shown in Figure 15.
Photograph reproduced with permission of Maria Schlumpf, Zürich.
Siegenthaler, Physician-in-Chief of the Medical Policlinic went
by the name of «little Napoleon» [«kleiner Napoleon»] among
his staff (169), in reference to Napoléon Bonaparte (1769–1821),
who has been described as the early nineteenth century dictator
of France (170). When confronted with the situation, Siegen-
thaler blamed the Government of the Cantone of Zürich (Zürcher
Regierungsrat) and denied any responsibility on his part, while
Grüntzig kept complaining to him that patients on waiting lists
for the new treatment were dying (37). Finally, Grüntzig also per-
sonally approached Peter Wiederkehr, member of the Zürcher
Regierungsrat, who also was unwilling to help (37). Only in
2009, shortly before Siegenthaler’s death (and more than 30 years
after Grüntzig’s first successful PTCA at the University of Zürich)
Siegenthaler publically admitted that he was afraid at the time that
he might have gone to prison should Grüntzig’s procedure had
failed (166). In an interview, which he gave in the U.S. in the early
1980s, Grüntzig stated:
«The only problem I had was a lack of beds in which to put the
patients, which caused a long waiting list for PTCA. Patients
on the waiting list were having their stenoses close completely,
getting MIs, and dying. [. . .] I was allowed to treat only two
patients a week in Zurich. When I came to Emory, I was able to
do two PTCA procedures a day.» (171).
Grüntzig began looking for a position in Germany at the University
of Tübingen, at the University of Frankfurt, and at the Univer-
sity of Düsseldorf, but without success. However, institutions in
the United States indicated that they would provide him with the
needed support that would allow him to further refine and advance
the PTCA method and to treat larger numbers of patients. Several
institutions, among them Harvard University and the Cleveland
Clinic, offered Grüntzig positions and he finally accepted an offer
from Emory University in Atlanta, GA, USA (131, 135). Unlike
Switzerland, the United States immediately realized Grüntzig’s
capacity and potential to advance cardiovascular medicine.
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FIGURE 15 | Photograph of attendees of the last angioplasty
demonstration course held at the Grosser Hörsaal Nord at the
Kantonspital of the University of Zürich in August 1980. Most of the
pioneers of transluminal and coronary angiography and angioplasty were
present, including Charles Dotter, M.D. (second row, 8th from right), Andreas
Grüntzig, M.D. (second row, 3rd from right), Melvin P. Judkins, M.D. (third
row, 9th from right), and F. Mason Sones, M.D. (fourth row, 4th from right).
Also shown are Maria Schlumpf (second row, 4th from right), Richard K.
Myler, M.D. (second row, 7th from right), Simon H. Sterzer, M.D. (second row,
12th from right), Grüntzig’s mother, Charlotte (fifth row, 3rd from right), as
well as Wilhelm Rutishauser, M.D. (third row, 8th from right) and Hans-Peter
Krayenbühl, M.D. (second row, 5th from right), who directed the cardiology
division at the Medical Policlinic between 1969 and 1980. Photograph
reproduced with permission of Maria Schlumpf, Zürich.
Grüntzig was classified as a “national treasure” by the authori-
ties in 1980 (172); however, he was never granted United States
citizenship (96). Emory University had just received a donation
of 105 million USD from the Coca-Cola Foundation (an amount
which in 2014 would equal approximately 250 million USD), one
of the biggest research grants ever given to an academic institution
(99), which allowed the hospital to expand on treatment of coro-
nary artery disease using balloon angioplasty technology. Grüntzig
accepted a Professorship at Emory University Medical School, with
the understanding to serve as the Director of Interventional Car-
diovascular Medicine at Emory (119). After his death, to honor and
acknowledge Grüntzig’s contributions and pioneering work in the
field, Emory University established the «Andreas Gruentzig Car-
diovascular Center» to further build upon Dr. Gruentzig’s progress
in the area of interventional cardiology (96, 173).
Twenty-five years after Grüntzig had died and only shortly
before his own death, Siegenthaler for the first time publically
claimed that “Grüntzig had lost sight of his boundaries,” that
he had become “rich and world-famous” in Atlanta, GA, USA,
and spread the idle rumor that fame and success had gotten to
Grüntzig’s head (166). At the same time, Siegenthaler contin-
ued to credit and portrait himself as the scientific midwife of
balloon angioplasty in books, articles, and on internet websites.
Notably, Siegenthaler listed Grüntzig’s article on coronary angio-
plasty published in the New England Journal of Medicine (75)
among his own most important publications («Die wichtigsten
Publikationen Walter Siegenthalers») (166).
At the last live demonstration course in Zürich in early August
of 1980, Dotter received a ring from Grüntzig as a token of appre-
ciation for his achievements in the field of cardiovascular medicine
(Figure 15). Upon his return to Oregon – Grüntzig had already
decided to leave the University of Zürich – Dotter, on August 22,
1980, in a personal letter (39) wrote to Grüntzig:
«You proved to be one of the most skilled catheterizers I have
ever seen; not only that but a superb teacher and a doctor who
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never forgot his patient. We will be happy to have you in this
country. [. . .]. In view of your accomplishments and compe-
tency it seems inconceivable that Zürich has not given you a
full professorship with tenure. Our gain will be their loss.» Dot-
ter continues: «I will admit that in the past I have been at
times jealous, especially when I heard people talking about the
Grüntzig procedure. I find no jealousy now, only admiration at
the thorough and innovative job you have done» [. . .] «The ring
is on my desk and I will continue to prize it. In an effort to give
you something, I am forwarding you a print of our 1968 film on
transluminal angioplasty. It’s long out of date, but has certain
historical significance.
Consider this a sentimental gift from me.[. . .]
Sein echtiger Freund [sic],
Charles T. Dotter»
Today, Dotter’s sentimental gift to Grüntzig is publicly avail-
able (73).
At Emory, Grüntzig had only 5 years left to continue teach-
ing and educating fellows and medical colleagues and continued
the angioplasty demonstration courses which he had started in
Zürich. Between 1980 and 1985, Grüntzig organized 10 courses
for his colleagues who came to Emory from all over the world to
receive his advice (167) (Figures 9 and 12). Spencer B. King, M.D.,
remembers Grüntzig’s qualities:
«Andreas was an incredibly bright and intense guy and very
committed to what he was doing, but at the same time he was
always open and encouraging of others. That’s what all of his
courses that he initially began were about — to share the knowl-
edge. He was active in all aspects of life — work, play, anything.
His motto was that if you really wanted something, you should
pay the price for it and not worry. He would not have been very
good at economizing on anything. He drove fast, he lived fast,
and he accomplished a lot in a short period of time.» (174)
In less than 5 years at Emory, Grüntzig performed more than 3,000
PTCA procedures,“without losing a single patient” (175); his pro-
fessionalism as a clinician is also evident from an episode told
by Spencer B. King, M.D., which happened during one of the
angioplasty demonstration courses held at Emory:
«One day during the lunch break of the course, Andreas was
leading a group of people who asked him if he would show them
the cath labs. At the same time John Douglas was doing a case on
a very obese woman. During the procedure, the woman had fib-
rillated and John defibrillated her. She literally bounced off the
table and onto the floor where John was kneeling, carefully keep-
ing the catheter in place. At that moment, Andreas opened the
door and came into the lab with about 10 people trailing behind
him. Within a second he assessed the situation and, before any-
one else could see, he quickly turned the group around, saying
‘Nothing happening here,’ and ushered everyone out.» (174)
While at Emory,Grüntzig continued meeting with Zeitler and Dot-
ter in Europe (Figure 16). Only a few months before Grüntzig’s
death, Milt Freudenheim, a journalist with The New York Times,
outlined the financial expectations associated with the predicted
FIGURE 16 |Top: Andreas Grüntzig, M.D. presenting Charles T. Dotter, M.D.
with a ring as a token of appreciation for his work in the field of
interventional vascular medicine. Shown applauding are Richard K. Myler,
M.D. and Simon H. Sterzer, M.D. (right). Bottom:Three vascular medicine
pioneers and founders of endovascular therapy (from left to right): Eberhard
Zeitler, M.D. (1930–2011), Andreas Grüntzig, M.D. (1939–1985), and Charles
Dotter, M.D. (1920–1985), discussing at a symposium held in 1982 in
Nürnberg, Germany. Top photograph reproduced with permission of Maria
Schlumpf, Zürich, bottom photograph reproduced with permission of Ernst
Schneider, M.D., Zürich.
growth of coronary angioplasty in cardiovascular medicine; he
also described how Grüntzig’s intellectual property of the balloon
catheter concept could not be secured by the company who first
manufactured the Grüntzig balloon catheter in Switzerland and
was soon sold to a larger company (175).
Shortly thereafter, Grüntzig gave his last interview at Emory
with Burt Cohen [available online (176)] where he also expresses
concerns about the safe future use of his invention:
«It is easy to be a hero and do a lot of dilatations and a lot of
stenoses, but you also then have to be a hero to face the family
in which you feel that probably the approach wasn’t right and
should have waited a day instead of getting in and trying to
elegantly do everything in one session and running into trouble
which could have been avoided. So if you want to be a hero so
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FIGURE 17 | (A) Examples of coil-spring, endarterial tube graft, and its percutaneous placement as introduced by Charles T. Dotter, M.D., in 1969.
(B) Balloon-expandable stents developed by Julio Palmaz, M.D. (A) reproduced from Ref. (178) and (B) reproduced from Ref. (183), with permission
of the publishers.
you better be it also in the follow-up and also when you face the
patient’s family after you had a trouble.» (176)
Andreas Grüntzig and his second wife, Margaret-Ann Grüntzig,
M.D. (née Thornton), unexpectedly died when his airplane
crashed at 3:33 p.m. on October 27, 1985, in Southeastern Monroe
county in Forsyth, GA, USA (28, 177). The investigation of the
crash that immediately followed Grüntzig’s tragic and early death
has not been conclusive. After 30 years, several questions remain
unresolved to this day (28, 177).
TRANSLUMINAL BALLOON ANGIOPLASTY: 40 YEARS ON
Building on Dotter’s initial idea that was based on an acciden-
tal observation (63, 64, 70), the use of balloon catheters intro-
duced by Grüntzig to restore blood flow in stenosed peripheral
and coronary arteries has developed into one of the most suc-
cessful therapeutic interventions of all time. As demonstrated by
Carrel in animal experiments a century ago (15), it was again
Dotter who already in 1964 developed the concept of endovas-
cular «splints» and who proposed to use endovascular stents as
non-biological structures to improve the stability of the diseased
arterial wall (60, 178) (Figure 17). Dotter, Rösch, and colleagues
were also the first to use a refined mode of application after bal-
loon angioplasty had been invented and introduced the word
“stent” to vascular medicine and for the treatment of peripheral
arteries (179, 180). The first coronary stent, initially designated
“coronary endo-prosthesis,” was deployed by Jacques Puel, M.D.
(1949–2008) at the University Hospital in Toulouse, France, on
March 26, 1986 (180, 181), the second one by Ulrich Sigwart,
M.D. in Lausanne on June 12, 1986 (182). The field experienced
an enormous development, in which Cesare Gianturco, M.D.
(1905–1995), Gary S. Roubin, M.D. Ph.D., Julio Palmaz, M.D.,
and Richard A. Schatz, M.D. (Figure 17) also made important
contributions (182–185).
Forty years after its introduction, balloon angioplasty contin-
ues to save lives of patients with acute myocardial infarction (131,
135, 140, 142). Balloon angioplasty saved patients from disability
by preventing leg amputations, as demonstrated by both Dotter
and Grüntzig with their very first patients (22, 60). The discovery
of balloon angioplasty represents perhaps one of the best early
examples of translational medicine in recent medical history (26,
140). What Dotter as early as 1964 in his first article (60) and
1968 in his film (73) envisioned to be applied in patients with
coronary artery disease some day, Grüntzig translated into clinical
application within a little more than a decade (26, 75, 161).
Coinciding with the 40th anniversary of the first balloon angio-
plasty in peripheral artery disease at the University of Zürich, the
U.S. FDA approved the first drug-coated balloon for peripheral
vascular interventions on October 12, 2014 (186), and correspond-
ing results were recently published by Jaff and associates (187).
Future applications of balloon angioplasty in humans may also
include the combination of adjuvant drug treatment targeting
disease mediators (6, 188).
In 2013, Grüntzig was posthumously awarded the «TCT Career
Achievement Award» for founding the field of interventional
cardiology (189). Although Grüntzig foresaw the developments
of balloon catheter application in many ways (in the 1980s,
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he expressed his interest in performing PTAs of extracranial
arteries – which has become clinical practice today), Grüntzig’s
clinical interests were by no means limited to interventional car-
diology. In fact, he had received extensive training in public health
and disease prevention and in the last years of his life also devel-
oped a keen interest in preventive cardiology, a field, which also
would see major developments in recent decades (6, 190).
ANDREAS GRÜNTZIG: THE HUMAN BEING
On June 25, 2014, Andreas Grüntzig would have celebrated his
75th birthday. It is most obvious that in his professional life as a
physician and as a scientist Grüntzig – in many ways – succeeded
in achieving more in half a lifetime than most of us ever will. He
did persevere against all obstacles that he was confronted with,
both in Germany and in Switzerland, with enormous will power,
optimism, intellect, hard work, and after all – remaining the same
person, “a real Mensch” that he had been since the early days. J.
Willis Hurst, M.D. (1920–2011), a close friend and colleague of
Grüntzig, remembered in 1986:
«What a role model he was. The greatest stimulus to learn-
ing is the behavior of another person who exhibits noble
attributes. Everyone who knew him realized he was unique.
As each individual discovered his great attributes, he or she
became a better person. This, I believe, was his greatest teaching
achievement.» (167).
Grüntzig’s personality also becomes apparent in his response when
he learned about the death of a close friend and colleague, Pierre
Wirz, M.D. (1935–1982). Grüntzig proclaimed: “God always calls
his most beloved ones first!” [Der Herrgott holt sich seine Lieblinge
zuerst!] (39). Wirz, who trained Grüntzig in coronary angiography,
and Pierre Levis, M.D., another close friend of Grüntzig (Figure 8),
started doing PTA procedures in peripheral arteries using the
Grüntzig balloon catheters at Triemli City Hospital in Zürich in
February of 1975. Thus, Levis, who is still active doing balloon
angioplasties, will soon also have a 40th angioplasty anniversary
to celebrate and thus has the longest experience of using Grüntzig
balloon catheters of anyone in the world today. Spencer B. King,
M.D., in an anecdote, reflects on Grüntzig’s personality:
«Sure he was a hard negotiator and demanding of others as
he was of himself, but when he perceived that others would be
hurt, he was very sensitive. Once while looking for office space, I
obtained a convenient suite of rooms for him near the cath lab.
Everything was set, but when he discovered the feelings of the
people who would be displaced, he refused the space. Dr. Hurst
came forward with alternative accommodations» (165)
The formed head of the Division of Thoracic and Cardiovascu-
lar Surgery at Heinrich-Heine Universität in Düsseldorf between
1972 and 1990, Wolfgang Bircks, M.D. (born 1927), remembers
visiting Andreas Grüntzig at Emory University Hospital in Atlanta
shortly before his death and recalls an extraordinary kindness in
the way Grüntzig treated his coworkers in the catheterization lab-
oratory. When Bircks met Andreas Grüntzig’s brother Johannes
after Grüntzig had died in the airplane crash, he offered him
his condolences and commented on his death with the following
words (191):
«Andreas Grüntzig made his exit like he used to make his
entrance: with a thunderbolt »
[«Andreas Grüntzig ist so abgetreten, wie er aufzutreten
pflegte: mit einem Donnerschlag !»]
Wolfgang Bircks, M.D.
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